Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

Chinese PLA General Hospital, Beijing

The First Hospital of China Medical University, Shenyang

The First Hospital of Jilin University, Changchun

Anhui Provincial Hospital, Hefei

The First Affiliated Hospital of Anhui Medical University, Hefei

Tianjin Medical University Cancer Institute & Hospital, Tianjin

Zhejiang Cancer Hospital, Hangzhou

Chongqing University Cancer Hospital, Chongqing

Hunan Cancer Hospital, Changsha

Hubei Cancer Hospital, Wuhan

Sun Yat-sen University, Cancer Center, Guangzhou

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Liaoning Cancer Hospital & Institute, Shenyang

Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou

West China Hospital, Sichuan University, Chengdu